Following antigen recognition, B cell receptor (BCR)-mediated endocytosis is the first step of antigen processing and presentation to CD4+ T cells, a crucial component of the initiation and control of the humoral immune response. Despite this, the molecular mechanism of BCR internalization is poorly understood. Recently, studies of activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) have shown that mutations within the BCR subunit CD79b leads to increased BCR surface expression, suggesting that CD79b may control BCR internalization. Adaptor protein 2 (AP2) is the major mediator of receptor endocytosis via clathrin-coated pits. The BCR contains five putative AP2-binding YxxØ motifs, including four that are present within two immunoreceptor tyrosine-based activation motifs (ITAMs). Using a combination of in vitro and in situ approaches, we establish that the sole mediator of AP2-dependent BCR internalization is the membrane proximal ITAM YxxØ motif in CD79b, which is a major target of mutation in ABC DLBCL. In addition, we establish that BCR internalization can be regulated at a minimum of two different levels: regulation of YxxØ AP2 binding in cis by downstream ITAM-embedded DCSM and QTAT regulatory elements and regulation in trans by the partner cytoplasmic domain of the CD79 heterodimer. Beyond establishing the basic rules governing BCR internalization, these results illustrate an underappreciated role for ITAM residues in controlling clathrin-dependent endocytosis and highlight the complex mechanisms that control the activity of AP2 binding motifs in this receptor system.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3553015PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0054938PLOS

Publication Analysis

Top Keywords

bcr internalization
20
mechanisms control
8
cell receptor
8
receptor endocytosis
8
bcr
8
abc dlbcl
8
ap2 binding
8
internalization
5
cis trans
4
trans regulatory
4

Similar Publications

Article Synopsis
  • BCAP (B cell adapter for PI 3-kinase) plays a critical role in B cell signaling, particularly in response to viral particles, but its specific function in antibody production was unclear.
  • Research shows that deleting BCAP in B cells reduces their ability to respond to specific antigens by impairing the process of endocytosis through the B cell receptor (BCR).
  • BCAP is essential for organizing actin around antigens for effective endocytosis and processing, which is crucial for presenting these antigens to T cells and facilitating B cell activation.
View Article and Find Full Text PDF

Envelope protein-specific B cell receptors direct lentiviral vector tropism in vivo.

Mol Ther

May 2024

Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; UCLA AIDS Institute, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address:

While studying transgene expression after systemic administration of lentiviral vectors, we found that splenic B cells are robustly transduced, regardless of the types of pseudotyped envelope proteins. However, the administration of two different pseudotypes resulted in transduction of two distinct B cell populations, suggesting that each pseudotype uses unique and specific receptors for its attachment and entry into splenic B cells. Single-cell RNA sequencing analysis of the transduced cells demonstrated that different pseudotypes transduce distinct B cell subpopulations characterized by specific B cell receptor (BCR) genotypes.

View Article and Find Full Text PDF

Post-transplant lymphoproliferative disorders (PTLDs) are associated with Epstein-Barr virus (EBV) infection in transplant recipients. Most of lymphoblastoid cell lines (LCLs) derived from EBV-immortalized B cells or PTLDs are sensitive to CD95-mediated apoptosis and cytotoxic T cell (CTL) killing. CD95 ligand (CD95L) exists as a transmembrane ligand (mCD95L) or a soluble form (sCD95L).

View Article and Find Full Text PDF

B-Cell Receptor Signaling and Beyond: The Role of Igα (CD79a)/Igβ (CD79b) in Normal and Malignant B Cells.

Int J Mol Sci

December 2023

BIOCEV, First Faculty of Medicine, Charles University, Prumyslova 595, 252 50 Vestec, Czech Republic.

Article Synopsis
  • B-cell receptor (BCR) is crucial for B cell functioning, and its components, CD79a and CD79b, are essential for the initiation and transmission of signals that support both normal and cancerous B cells.
  • Recent studies highlight the complexity of CD79a/CD79b signaling, revealing their role in signal integration and the survival of B cells, implying their importance in both health and disease.
  • The review discusses how mutations in BCR signaling pathways affect normal B cell activity, raises unresolved questions about CD79a/CD79b function, and suggests potential therapeutic targets for treating B cell-related diseases.
View Article and Find Full Text PDF

In B cells, antigen processing and peptide-antigen (pAg) presentation is essential to ignite high-affinity antibody responses with the help of cognate T cells. B cells efficiently internalize and direct specific antigens for processing and loading onto MHCII. This critical step, which enables pAg presentation, occurs in MHCII compartments (MIICs) which possess the enzymatic machinery for pAg loading on MHCII.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!